Journal details
JOURNAL OF NEUROIMMUNE PHARMACOLOGY
SPRINGER · ISSN 1557-1890 · eISSN 1557-1904
SCIEScopusMEDLINEPubMedPMC
Overview
JOURNAL OF NEUROIMMUNE PHARMACOLOGY. ISSN 1557-1890 · eISSN 1557-1904. published by SPRINGER. United States. Neurosciences · Pharmacology & Pharmacy. impact factor 6.1 (2025). JCR Q1. CAS Zone 3. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 28 articles · 2025: 106 articles · 2024: 61 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of JOURNAL OF NEUROIMMUNE PHARMACOLOGY?
The impact factor recorded for JOURNAL OF NEUROIMMUNE PHARMACOLOGY is 6.1 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of JOURNAL OF NEUROIMMUNE PHARMACOLOGY?
JOURNAL OF NEUROIMMUNE PHARMACOLOGY is listed in CAS Zone 3.
Which databases index JOURNAL OF NEUROIMMUNE PHARMACOLOGY?
JOURNAL OF NEUROIMMUNE PHARMACOLOGY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.